Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MFSD13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MCEE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM106C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928589 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NIPAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF170 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGFG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MED28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on